Ha Tay Pharmaceutical JSC (HNX:DHT)

Vietnam flag Vietnam · Delayed Price · Currency is VND
71,000
+1,000 (1.43%)
At close: Apr 28, 2026
-6.35%
Market Cap 6.43T
Revenue (ttm) 2.40T
Net Income (ttm) 53.66B
Shares Out 90.57M
EPS (ttm) 645.11
PE Ratio 110.06
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 13,000
Average Volume 8,508
Open 71,000
Previous Close 70,000
Day's Range 68,000 - 71,000
52-Week Range 66,200 - 86,800
Beta 0.22
RSI 53.92
Earnings Date May 8, 2026

About Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, pharmaceutical chemicals, and cosmetics and medical equipment primarily in Vietnam. The company provides medical material, medicinal food, and hygiene products. It also engages in the real estate; and land use rights owned, used, or leased businesses. In addition, the company produces and sells functional food products; and engages in wholesale of food products, as well as contract manufacturing services for pharmaceutical and functional food products. The compan... [Read more]

Industry Pharmaceutical Preparations
Founded 1965
Employees 586
Stock Exchange Hanoi Stock Exchange
Ticker Symbol DHT
Full Company Profile

Financial Performance

In 2025, Ha Tay Pharmaceutical JSC's revenue was 2.40 trillion, an increase of 15.13% compared to the previous year's 2.09 trillion. Earnings were 53.66 billion, a decrease of -25.24%.

Financial Statements

News

There is no news available yet.